STAT+

In the Lab Jason Mast

STAT Plus: Trying to outrun her prion disease, researcher creates powerful epigenetic editor in mice

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about EMA plans for GLP-1 shortages, Walgreens store closings, and more

Health tech Nicholas St. Fleur

STAT Plus: Q&A: Defining responsible AI in health care, with CHAI CEO Brian Anderson

In the Lab Angus Chen

STAT Plus: Journal retracts study tied to Micronoma’s effort to create cancer blood test

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about rejection of an AbbVie Parkinson’s drug, PBM markups on mail order, and more

Exclusive Allison DeAngelis

STAT Plus: Biotech accelerator Curie.Bio extends its reach with new $380 million fund

Health tech Brittany Trang

STAT Plus: Q&A: How Flagship’s Cellarity is using AI to understand cell disease biology before treating it

Health Isabella Cueto

STAT Plus: Standalone organ donor centers have sprouted all over the U.S. Do they work better than hospitals?

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Novo’s Wegovy approval in China, a Merck KGaA cancer trial failure, and more

Pharmalot Ed Silverman

STAT Plus: U.K. pharma increasingly violates voluntary industry marketing codes, and probes are taking longer

Biotech Jason Mast

STAT Plus: Former Moderna executive launches genome editing company

Health tech Mario Aguilar

STAT Plus: AliveCor gets FDA nod for portable 12-lead, AI-powered ECG device

Opinions+ Ashu Singhal and Sajith Wickramasekara

STAT Plus: Could billions of dollars in AI funding lead to the same number of new drugs?

Health tech Lizzy Lawrence and Elaine Chen

STAT Plus: Experts split on whether Eli Lilly’s Zepbound will hamper CPAP sales

Biotech Matthew Herper

STAT Plus: Grail, aiming to market a blood test for cancer, faces host of challenges as it debuts on Nasdaq

Hospitals Mohana Ravindranath

STAT Plus: HHS finalizes penalties for providers resorting to ‘information blocking’

In the Lab Mohana Ravindranath

STAT Plus: Oral ketamine tablets effective for treating depression, new study finds

Hospitals Hanna Krueger — Boston Globe

STAT Plus: Steward Health Care executives are mired in trouble at home. In Malta, it’s much worse

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a plan for Medicare coverage of Wegovy, an Alnylam heart drug, and more

Biotech Elaine Chen

STAT Plus: Alnylam reports positive results for heart drug in pivotal study, likely clearing path to approval

Health tech Mohana Ravindranath

STAT Plus: Ateev Mehrotra, the researcher the telehealth lobby loves to hate, isn’t backing down

Health tech Lizzy Lawrence

STAT Plus: Q&A: How Kaiser Permanente tracks and weeds out risky medical devices

Hospitals Tara Bannow

STAT Plus: The CEO of Kaiser’s new health network shares why he’s making a bet on a tiny North Carolina hospital system

Health Isabella Cueto and Angus Chen

STAT Plus: Jury orders Stanford to pay millions to employee in racial harassment case

Health Elizabeth Cooney

STAT Plus: Vertex reports positive results in stem cell trial for type 1 diabetes

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests

Business Tara Bannow

STAT Plus: Kaiser adds a small North Carolina health system to its Risant Health network

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Biotech Adam Feuerstein

STAT Plus: What the Sarepta decision means for Duchenne patients, the company, and the FDA